arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Amylyx Pharmaceuticals, Inc.

AMLX Health Care Biotechnology: Pharmaceutical Preparations
$13.32
▼ -6.9% Today
as of Jun 7, 07:08 ET
Last 30 days -18.33% Apr 28 → Jun 05
$12.44 $13.52 $14.60 $15.68 $16.76 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$14.25
High
$14.47
Low
$12.96
Volume
$2M
Avg Vol
$1M
Mkt Cap
$1.6B
P/E (TTM)
Beta
52w High
$18.61
52w Low
$4.76
Div Yield
Shares Out
$111M

Overview

52-week range
$4.76
$19
62% of range
Avg surprise (last 2)
-1.1%
Avg reaction (last 2)
-5.7%
0% positive
Latest IV / EM
87%
EM ±12.0% · $13 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.75$-1.23$-0.72$-0.21$0.31 Actual $0.31Actual $0.30Actual $-1.75Actual $-1.07Actual $-1.07Actual $-0.42Est $-0.45Actual $-0.46Actual $-0.37Actual $-0.37Est $-0.34 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-73M$-64M$-54M$-45M$-36M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.37 $-0.34 -8.8% +11.9% -5.4% earnings
Tue Sep 30, 2025Sep 2025 $-0.37 financials
Mon Jun 30, 2025Jun 2025 $-0.46 financials
Thu May 8, 2025Mar/2025 $-0.42 $-0.45 +6.7% -6.0% earnings
Mon Sep 30, 2024Sep 2024 $-1.07 financials
Sun Jun 30, 2024Jun 2024 $-1.07 financials
Sun Mar 31, 2024Mar 2024 $-1.75 financials
Sat Sep 30, 2023Sep 2023 $0.30 financials
Fri Jun 30, 2023Jun 2023 $0.31 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$0$0$0$0$8,000
Gross profit
Operating income$-44M$-36M$-43M$-38M$-76M$-76M
Net income$-41M$-34M$-41M$-36M$-73M$-73M
EPS (diluted)$-0.37$-0.37$-0.46$-0.42$-1.07$-1.07

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$229M$227M$225M$58M$60M$77M$72M$75M
Inventory
Total current assets$285M$324M$353M$187M$216M$189M$245M$327M
Total assets$294M$333M$363M$195M$220M$194M$251M$332M
Long-term debt
Total liabilities$20M$27M$31M$27M$18M$29M$55M$71M
Total equity$273M$305M$332M$168M$201M$165M$196M$261M

Implied volatility — last 90 days

81%84%86%89%91% Jun 07 — IV 87% · EM ±12.0%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.